about
Metabolomics: moving towards personalized medicineInter-society consensus document on treatment and prevention of bronchiolitis in newborns and infantsThe labyrinth of asthma phenotypes and exhaled NOInternational consensus on (ICON) pediatric asthmaSystems medicine and integrated care to combat chronic noncommunicable diseases.Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years.Assessment of pediatric asthma drug use in three European countries; a TEDDY study.Longitudinal monitoring of lung injury in children after acute chlorine exposure in a swimming pool.Validating a set of tools designed to assess the perceived quality of training of pediatric residency programs.Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school childrenCysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.Lung function tests in neonates and infants with chronic lung disease: forced expiratory maneuvers.Airway function measurements and the long-term follow-up of survivors of preterm birth with and without chronic lung disease.Exercise testing and chronic lung diseases in children.Exhaled nitric oxide in children with asthma and sinusitis.Chronic lung disease after premature birth.A short questionnaire to assess pediatric resident's competencies: the validation process.Childhood asthma and environmental exposures at swimming pools: state of the science and research recommendations.Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach.Swimming pool, respiratory health, and childhood asthma: should we change our beliefs?International child health elective for pediatric residentsEndpoints in respiratory diseases.Immunotherapy for food allergies in children.Chronic lung disease of prematurity: long-term respiratory outcome.Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing.Severe asthma in childhood: diagnostic and management challenges.Monitoring asthma in children.Childhood asthma biomarkers: present knowledge and future steps.Regular vs prn nebulized treatment in wheeze preschool children.Exhaled breath condensate: methodological recommendations and unresolved questions.RSV--still more questions than answers.Safety and success of exhaled breath condensate collection in asthma.Bronchopulmonary dysplasia: definitions and long-term respiratory outcome.Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation.Increased exhaled 8-isoprostane in childhood asthma.High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study.From BPD to COPD? The hypothesis is intriguing but we lack lung pathology data in humans.Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma.Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.Gender differences in the effectiveness of asthma treatment.
P50
Q21198748-35D9AC75-F54A-42B2-809F-F52AB17D2348Q27027386-63E0AB01-9715-4E17-B6DD-3FFF6F8A5A8DQ28363310-F0CADBB6-3D55-4858-97D1-82A25DDC4907Q30393965-83EBDB26-EFB3-42CB-90AA-F4FFDE4038E7Q30395763-86DFD597-3D65-4B12-8B72-D7237C472674Q34424366-000B9F1D-80F9-4979-92AB-35598B3B4F2EQ34467637-A2DE9D88-A77A-4D82-8668-6BE9417A1030Q35009431-C1027BE3-3625-4126-A268-BF2839DC24CFQ35116131-CA6E198B-E897-4892-801D-70222AA4E500Q35207106-19B9235D-17BD-4F84-ABD0-72A23DDD0464Q35535997-5565DF69-25BD-4E27-B254-9EF9F02A67BDQ36313249-89B05806-87AD-457E-A00C-EF768D3E8C05Q36450485-045AA182-B266-4EA4-AFDB-5F8B7370E3C1Q36518226-34BE2059-1FA8-44DC-A9CD-3E9723864CAAQ36927682-9AC74E58-957E-4E13-BE94-D07A9EF633A1Q36995880-19168B51-D3DE-49BD-BD28-3CFA56614F49Q37053372-49897D57-4360-4BEA-BCF5-6A209613F273Q37185571-038F32F9-8259-4338-94B5-90774FE3318DQ37283122-BBCB8BF7-1984-4072-BF5B-9101CBF4DE15Q37342943-95A6E1CB-6C3C-4384-B6E8-8CA362B4933DQ37580587-0FDC4209-8412-44E7-9CA5-A4E261E4CEC4Q37812021-060B7105-48B9-4010-A675-EA2B9A6C4E8BQ38108876-020FB339-9CC2-4DFC-9723-184B4C93C7A8Q38220426-81282A7C-88B7-41DD-A219-E6A67CDD039FQ38260879-FF786646-12A9-47BA-9F7C-50C47D22032CQ38270279-CE01CAC1-BEC8-46A6-B48E-6E841F3B4966Q38368506-323B67CB-5E1C-4364-BC51-423983D1BEEFQ38534764-0A4D2571-8D56-4F68-A3E8-F35C3F6AC47EQ39298294-B001AD7D-BA28-4B13-AE5E-E31164542D98Q40392502-02F38BB0-F42B-48A3-BE93-5CF6F6D3BBBDQ42197373-CF9780C4-4347-4293-9BE0-EE12CC31EAC3Q42719916-E95D5B89-8FF0-4E39-BABF-C363B8BBD250Q43774465-14D5EDF8-7488-41A0-BE42-A8FAE9E214D1Q44201538-AAF23354-9E92-44FC-80E7-0135FA49FF50Q44508502-95FB3BB2-D995-4D87-AAFB-B0A608B9DEDAQ46243372-225E8D07-7298-4AE8-B5D1-910ADECEE4A0Q46309181-336F8813-F76B-4553-8E73-1228304CC826Q46309541-A8F73E97-E71A-4734-A5F6-45D7E9F49FD5Q46418175-F22193CE-CE84-49A8-9E90-12BDC947E11FQ46562816-751C9388-541E-497D-8C21-2FA67ABFA1FA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eugenio Baraldi
@ast
Eugenio Baraldi
@en
Eugenio Baraldi
@es
Eugenio Baraldi
@nl
type
label
Eugenio Baraldi
@ast
Eugenio Baraldi
@en
Eugenio Baraldi
@es
Eugenio Baraldi
@nl
prefLabel
Eugenio Baraldi
@ast
Eugenio Baraldi
@en
Eugenio Baraldi
@es
Eugenio Baraldi
@nl
P106
P1153
7006821460
P21
P31
P496
0000-0002-1829-3652